ELVN - Enliven Therapeutics, Inc.

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
EPS Growth YoY (%)	33.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-4.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	33.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-19.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-5.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-0.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	5.9% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	32.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	84.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-183.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	6.8% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	—	-447.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	67.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	40.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	17.2% Good ↑ Good Improving Year-over-year change in net income	-28.0% Weak ↓ Weak Declining Year-over-year change in net income	-25.5% Weak ↓ Weak Declining Year-over-year change in net income	-25.5% Weak ↑ Weak Improving Year-over-year change in net income	-25.5% Weak ↑ Weak Improving Year-over-year change in net income	-19.7% Weak ↑ Weak Improving Year-over-year change in net income	-54.4% Weak ↑ Weak Improving Year-over-year change in net income	-54.4% Weak → Weak Stable Year-over-year change in net income	-54.4% Weak ↓ Weak Declining Year-over-year change in net income	-102.8% Weak ↓ Weak Declining Year-over-year change in net income	-0.6% Weak ↓ Weak Declining Year-over-year change in net income	-0.6% Weak ↑ Weak Improving Year-over-year change in net income	-0.6% Weak ↑ Weak Improving Year-over-year change in net income	33.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-42.7% Weak ↓ Weak Declining Year-over-year change in net income	-42.7% Weak ↓ Weak Declining Year-over-year change in net income	-42.7% Weak ↓ Weak Declining Year-over-year change in net income	-24.3% Weak ↑ Weak Improving Year-over-year change in net income	-42.2% Weak ↑ Weak Improving Year-over-year change in net income	-42.2% Weak ↑ Weak Improving Year-over-year change in net income	-42.2% Weak ↑ Weak Improving Year-over-year change in net income	-58.9% Weak ↑ Weak Improving Year-over-year change in net income	-72.0% Weak → Weak Stable Year-over-year change in net income	-72.0% Weak Weak Year-over-year change in net income	-72.0% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	36.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	13.2% Fair Fair Year-over-year change in free cash flow	—	—	—	50.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
FCF / Net Income (x)	0.82x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.42x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.17x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.27x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.32x Good → Good Stable Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.50x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.23x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-4.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-5.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-4.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-7.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-7.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	10.5% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-10.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	12.1% Good → Good Stable Return earned on debt + equity capital invested Optimal: > 10%	13.0% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	12.3% Good Good Return earned on debt + equity capital invested Optimal: > 10%	10.9% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-6.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-7.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-5.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-8.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-15.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-12.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-9.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-22.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-5.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	-6.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	-6.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-140%)	-5.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	-9.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-7.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	-7.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	-7.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	-7.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-148%)	-7.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	-5.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	-5.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	-5.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	12.4% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-17%)	-25.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-270%)	-23.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-259%)	-20.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-235%)	-16.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-211%)	-10.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-169%)	-15.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-205%)	-13.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-190%)	-13.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-7.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-151%)	-6.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	-6.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	14.8% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	10.0% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-33%)	11.8% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-21%)	13.8% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-8%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Net Debt (USD)	$-132.18M	$-98.90M	$-101.73M	$-119.44M	$-101.70M	$-124.12M	$-100.62M	$-96.87M	$-149.16M	$-100.14M	$-73.85M	$-125.72M	$-292.10M	$-75.54M	$-49.49M	$-30.43M	$-36.48M	$-48.31M	$-75.30M	$-48.04M	$-53.44M	$-47.70M	$-34.16M	$-54.65M	$-86.72M	$-4.94M	$-17.09M	$-45.23M	$-48.90M	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Basic EPS, GAAP (USD)	$-0.38	$-0.48	$-0.32	$-0.49	$-0.57	$-0.46	$-0.48	$-0.41	$-0.54	$-0.46	$-0.51	$-0.41	$-0.80	$-2.90	$-0.18	$-0.44	—	$-0.53	$-0.55	$-0.74	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.31	—	$-0.21	$-0.33	$-0.48	—	—	—	$-0.56	—	—	—	$-1.13	—	—	—	—	—	$-0.44	$-0.59	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$7.45	$7.73	$8.03	$8.25	$5.88	$6.33	$6.10	$6.46	$6.79	$5.96	$6.35	$6.78	$7.11	$-21.52	$2.18	$2.33	$2.75	$3.27	$3.99	$3.67	$4.29	$4.81	$5.45	$6.14	$6.35	$-69.53	—	—	—	—
Tangible Book Value per Share (USD)	$7.45	$7.73	$8.03	$8.25	$5.88	$6.33	$6.10	$6.46	$6.79	$5.96	$6.35	$6.78	$7.11	$-21.52	$2.18	$2.33	$2.75	$3.27	$3.99	$3.67	$4.29	$4.81	$5.45	$6.14	$6.35	$-69.53	—	—	—	—
Basic Weighted Avg Shares (shares)	62.80M	—	62.09M	52.11M	50.05M	—	48.27M	48.08M	42.05M	—	41.03M	40.96M	18.51M	—	26.29M	26.29M	—	—	24.90M	17.72M	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$451.65M	$458.31M	$468.03M	$480.41M	$280.35M	$302.21M	$279.97M	$296.02M	$312.17M	$240.26M	$256.53M	$274.03M	$287.06M	$68.04M	$57.29M	$60.95M	$71.31M	$85.49M	—	—	$74.86M	$84.16M	$94.40M	$105.75M	$104.87M	$26.43M	—	—	—	—
Total Equity (USD)	$453.37M	$459.60M	$476.12M	$488.47M	$288.30M	$309.85M	$288.40M	$304.93M	$317.71M	$245.91M	$261.75M	$278.99M	$291.42M	$-76.83M	$57.29M	$61.36M	$72.41M	$86.03M	$99.37M	$64.97M	$75.59M	$84.44M	$94.70M	$106.30M	$105.19M	$-48.85M	$-41.90M	$-35.62M	$-30.41M	$-26.32M

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Depreciation Expense (USD)	$14.00K	$83.00K	$62.00K	$81.00K	$74.00K	$63.00K	$80.00K	$79.00K	$79.00K	$80.00K	$79.00K	$74.00K	$67.00M	$49.00K	—	—	$25.00K	$25.00K	$24.00K	$25.00K	$25.00K	$23.00K	—	—	$24.00K	$25.00K	—	—	—	—
Net Income, GAAP (USD)	$-23.63M	$-29.67M	$-28.54M	$-28.54M	$-28.54M	$-23.18M	$-22.74M	$-22.74M	$-22.74M	$-19.37M	$-14.72M	$-14.72M	$-14.72M	$-9.55M	$-14.64M	$-14.64M	$-14.64M	$-14.32M	$-10.26M	$-10.26M	$-10.26M	$-11.52M	$-7.21M	$-7.21M	$-7.21M	$-7.25M	$-4.19M	$-4.19M	$-4.19M	—
Operating Cash Flow (USD)	$-19.29M	$-15.84M	$-13.28M	$-17.06M	$-24.13M	$-17.20M	—	—	$-23.36M	$-12.48M	—	—	$-20.84M	$-8.14M	—	—	$-17.16M	$-12.48M	$-10.90M	$-10.37M	$-13.02M	$-8.27M	—	—	$-9.53M	$-8.04M	$-6.28M	$-5.15M	$-2.41M	—

Enliven Therapeutics, Inc.

Analytical Summary

30-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare ELVN with peers